Jieli Lu
Impact in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diet, Metabolism, and Disease
-
- Effects and risks of endocrine disrupting chemicals
Papers in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 23
- Epidemiology 35
- Liver Disease Diagnosis and Treatment 23
- Neuroendocrine Tumor Research Advances 8
- Co-authors
- Yufang Bi (173 shared papers)Guang Ning (140 shared papers)Min Xu (138 shared papers)Weiqing Wang (153 shared papers)Yu Xu (135 shared papers)Tiange Wang (133 shared papers)Yuhong Chen (90 shared papers)Mian Li (115 shared papers)
- Journals
- Journal of Diabetes (30 papers)The Journal of Clinical Endocrinology & Metabolism (15 papers)PLoS ONE (7 papers)Cardiovascular Diabetology (5 papers)Liver International (5 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Jieli Lu
212 papers receiving 5.2k citations
Jieli Lu's Hit Papers
Peers
Comparison fields: 5 of 142
- Endocrinology, Diabetes and Metabolism 877
- Health, Toxicology and Mutagenesis 604
- Epidemiology 1.2k
- Nephrology 215
- Cardiology and Cardiovascular Medicine 463
Countries citing papers authored by Jieli Lu
This map shows the geographic impact of Jieli Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jieli Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jieli Lu more than expected).
Fields of papers citing papers by Jieli Lu
This network shows the impact of papers produced by Jieli Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jieli Lu. The network helps show where Jieli Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Jieli Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 221 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 289 | |
| 2 | 2016 | 190 | |
| 3 | 2015 | 152 | |
| 4 | 2013 | 120 | |
| 5 | 2012 | 120 | |
| 6 | 2015 | 118 | |
| 7 | 2019 | 108 | |
| 8 | 2010 | 107 | |
| 9 | 2012 | 103 | |
| 10 | 2012 | 95 | |
| 11 | 2013 | 95 | |
| 12 | 2009 | 93 | |
| 13 | 2009 | 88 | |
| 14 | 2012 | 74 | |
| 15 | 2012 | 68 | |
| 16 | 2015 | 64 | |
| 17 | 2014 | 63 | |
| 18 | 2015 | 61 | |
| 19 | 2020 | 60 | |
| 20 | 2013 | 58 |
About Jieli Lu
Jieli Lu is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology, Genetics, Molecular Biology and Cardiology and Cardiovascular Medicine, having authored 221 papers that have together received 5.3k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (23 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (23 papers), Genetic Associations and Epidemiology (17 papers), Pancreatic function and diabetes (12 papers), Cardiovascular Health and Disease Prevention (9 papers), Metabolism, Diabetes, and Cancer (8 papers), Neuroendocrine Tumor Research Advances (8 papers) and Effects and risks of endocrine disrupting chemicals (8 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (877 citations), Health, Toxicology and Mutagenesis (604 citations), Epidemiology (1.2k citations), Nephrology (215 citations) and Cardiology and Cardiovascular Medicine (463 citations). Jieli Lu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Yufang Bi, Guang Ning, Min Xu, Weiqing Wang, Yu Xu, Tiange Wang, Yuhong Chen, Mian Li, Zhiyun Zhao and Shenghan Lai. Their work appears in journals such as Journal of Diabetes, The Journal of Clinical Endocrinology & Metabolism, PLoS ONE, Cardiovascular Diabetology and Liver International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.